Research graph
References from Personalized messenger RNA therapy for melanoma and the challenge of global implementation. Local targets link to admitted publications; unresolved targets remain external evidence.
Personalized RNA mutasome vaccines mobilize poly-specific therapeutic immunity against cancer
10.1038/nature23003 · 2017 · External reference
An immunogenic personal neoantigen vaccine for patients with melanoma
10.1038/nature22991 · 2017 · External reference
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
10.1016/s0140-6736(23)02268-7 · 2024 · External reference
Intismeran autogene plus pembrolizumab versus pembrolizumab alone in high-risk resected melanoma: 5-year update of the randomized phase IIb KEYNOTE-942 study
10.1200/jco-26-00835 · 2026 · External reference
